🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07588295
Recruiting Not applicable

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

NCT07588295 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2024-03-18
Last updated
2026-05-14

Condition(s) studied

Stable Coronary Artery DiseaseAcute Coronary SyndromesCritical Limb IschemiaIntermittent Claudication

Investigational drug(s) / intervention(s)

Optical Coherence Tomography assessment

Optical Coherence Tomography assessment: assessment of the number of infiltrating macrophages

Study summary

Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages.

This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate these findings with the distribution of circulating monocyte subpopulations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with chronic coronary artery disease; * Patients with no-ST elevation acute coronary syndrome; * Patients with chronic claudication (Rutherford II-III) * Patients with critical limb ischemia (Rutherford IV-V). Exclusion Criteria: * Severe renal dysfunction * Severe valve disease * Advanced heart failure * Advanced liver disease * Chronic inflammatory or autoimmune disease * Use of antinflammatory drugs * Acute infection * Recent surgical procedures

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Maria Cecilia Hospital Cotignola Ravenna Recruiting

More Maria Cecilia Hospital trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07588295 on ClinicalTrials.gov ↗ ← All trials in Italy